DE69635667D1 - Biologisch aktive liganden der eph familie - Google Patents

Biologisch aktive liganden der eph familie

Info

Publication number
DE69635667D1
DE69635667D1 DE69635667T DE69635667T DE69635667D1 DE 69635667 D1 DE69635667 D1 DE 69635667D1 DE 69635667 T DE69635667 T DE 69635667T DE 69635667 T DE69635667 T DE 69635667T DE 69635667 D1 DE69635667 D1 DE 69635667D1
Authority
DE
Germany
Prior art keywords
biologically active
active ligands
eph family
eph
ligand
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69635667T
Other languages
English (en)
Other versions
DE69635667T2 (de
Inventor
Samuel Davis
W Gale
D Yancopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regeneron Pharmaceuticals Inc
Original Assignee
Regeneron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21723735&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69635667(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Regeneron Pharmaceuticals Inc filed Critical Regeneron Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69635667D1 publication Critical patent/DE69635667D1/de
Publication of DE69635667T2 publication Critical patent/DE69635667T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69635667T 1995-10-25 1996-10-25 Biologisch aktive liganden der eph familie Expired - Lifetime DE69635667T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US701595P 1995-10-25 1995-10-25
US7015P 1995-10-25
PCT/US1996/017201 WO1997015667A1 (en) 1995-10-25 1996-10-25 Biologically active eph family ligands

Publications (2)

Publication Number Publication Date
DE69635667D1 true DE69635667D1 (de) 2006-02-02
DE69635667T2 DE69635667T2 (de) 2006-09-07

Family

ID=21723735

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635667T Expired - Lifetime DE69635667T2 (de) 1995-10-25 1996-10-25 Biologisch aktive liganden der eph familie

Country Status (8)

Country Link
US (2) US6602683B1 (de)
EP (1) EP0859840B1 (de)
JP (1) JPH11514238A (de)
AT (1) ATE314470T1 (de)
AU (1) AU712737B2 (de)
DE (1) DE69635667T2 (de)
IL (1) IL124202A (de)
WO (1) WO1997015667A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842272A4 (de) * 1995-07-20 2002-03-06 Amrad Operations Pty Ltd Neuartige rezeptorliganden und genetische sequenzen, welche für diese kodieren
US6696557B1 (en) * 1996-04-19 2004-02-24 Genentech, Inc. AL-2 neurotrophic factor nucleic acid
EP1141294B1 (de) 1998-12-23 2005-03-02 Regeneron Pharmaceuticals, Inc. Methode zur verstärkung der biologischen aktivität von liganden
EP2096174A1 (de) * 2008-02-28 2009-09-02 Centro De Investigación Cooperativa En Biociencias CiC bioGune Ubiquitin-bindende Polypeptide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3560609B2 (ja) 1992-11-13 2004-09-02 イミュネックス・コーポレーション Ｅｌｋリガンドと呼ばれる新規なサイトカイン
US6303769B1 (en) * 1994-07-08 2001-10-16 Immunex Corporation Lerk-5 dna
WO1996026958A2 (en) * 1995-02-27 1996-09-06 President And Fellows Of Harvard College Eph RECEPTOR LIGAND ELF-2
EP0842272A4 (de) * 1995-07-20 2002-03-06 Amrad Operations Pty Ltd Neuartige rezeptorliganden und genetische sequenzen, welche für diese kodieren
KR19990087793A (ko) * 1996-03-21 1999-12-27 크리스토퍼 엘. 와이트, 스코트 지. 홀퀴스트, 스티븐 엘. 말라스카 러크-8로 표시된 싸이토킨
US6696557B1 (en) * 1996-04-19 2004-02-24 Genentech, Inc. AL-2 neurotrophic factor nucleic acid

Also Published As

Publication number Publication date
WO1997015667A1 (en) 1997-05-01
DE69635667T2 (de) 2006-09-07
JPH11514238A (ja) 1999-12-07
ATE314470T1 (de) 2006-01-15
AU7477896A (en) 1997-05-15
US6602683B1 (en) 2003-08-05
IL124202A (en) 2006-06-11
US20030215918A1 (en) 2003-11-20
AU712737B2 (en) 1999-11-11
EP0859840B1 (de) 2005-12-28
EP0859840A1 (de) 1998-08-26

Similar Documents

Publication Publication Date Title
DK0669929T3 (da) Elk-ligand, et cytokin
DK0758383T3 (da) Oplöselige polypeptidfraktioner af LAG-3-proteinet; fremgangsmåde til fremstilling; terapeutisk sammensætning; antiidiotypisk antistof
DE68929402D1 (de) Verfahren zur herstellung von wasserlöslichen polypeptiden
ATE232901T1 (de) Biologisch aktive ligande der eph familie
ATE324441T1 (de) Htk-ligand
DK0760857T5 (da) Receptor for onkostatin M
FI104180B1 (fi) Menetelmä polypeptidin vasta-aineen ekä IL-4 välittämien tilojen hoitoon tarkoitetun seoksen valmistamiseksi
ATE456654T1 (de) Löslicher zytokinrezeptor zalpfa11
DK624884A (da) Peptider
WO2002012345A3 (en) Soluble zcytor 11 cytokine receptors
CA2011450A1 (en) Recombinant b-chain of the il-2 receptor
ATE212059T1 (de) Methoden zur identifizierung heterofunktionaler fusionsproteine
DE3582895D1 (de) Peptid, dessen herstellung und benutzung.
PL349158A1 (en) Method of enhancing the biological activity of ligands
ATE314470T1 (de) Biologisch aktive liganden der eph familie
DE69935782D1 (de) Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna
KR930701487A (ko) 식물성 독소 겔로닌의 단백질 구조물
DK0656117T3 (da) Fremgangsmåde til udvælgelse af superagonister, antagonister og superantagonister for interleukin 6
CA2236001A1 (en) Biologically active eph family ligands
DE3856069D1 (de) Cdna, die für peptidyl-glycin alphaamidierende monooxygenase (pam) codiert
DE59911530D1 (de) Zellpermeabilität-vermittelndes polypeptid
ATE386114T1 (de) Gene, die für lymphocyte spezifischen interferon- regulationsfaktor (lsirf) polypeptide kodiert
ES2033212A6 (es) Procedimiento para la obtencion de peptidos puramente glicosilados, parcialmente glicosilados o no glicosilados.
EP1736545A3 (de) Lösliche Zcyctor 11 Cytokinrezeptoren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition